AstraZeneca’s Brilinta won its coveted stroke-prevention nod. Will it be enough to boost long-term sales?

AstraZeneca’s Brilinta won its coveted stroke-prevention nod. Will it be enough to boost long-term sales?
aliu
Fri, 11/06/2020 – 09:45